Author： Edwards I. Ralph
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.28, Iss.8, 2005-01, pp. : 651-658
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
What's the real cost of preventing chronic disease in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 572, 2009-01 ,pp. :
Access to resources
Recommend
Should the risks associated with Vioxx have come to light sooner?
Reactions Weekly, Vol. 1, Iss. 1281, 2009-01 ,pp. :
NICE Says No to Inhaled Insulin: What Lessons Should We Learn?
PharmacoEconomics, Vol. 24, Iss. 7, 2006-01 ,pp. :
Switch from prescription-only to OTC at what cost?
Inpharma, Vol. 1, Iss. 1306, 2001-01 ,pp. :
Pharmaceutical Innovation, Vol. 11, Iss. 2, 2002-03 ,pp. :